Buy or sell Q Bio stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Q Bio Stock

On a mission to build the first Clinical Digital Twin Platform and make it accessible to everyone

About Q Bio Stock

Q Bio was founded in 2015 by Jeffrey Kaditz, serial entrepreneur and Founder of Affirm, Dr Michael Snyder, Chair of Genetics and Director of Personalized Medicine and Stanford University, and Dr Garry Choy, physician, radiologist, and former Chief Medical Information Officer at Mass General Hospital. Q Bio is fortunate to be backed by some of the best venture groups in the world including: A16Z, Khosla Ventures, Founders Fund, SciFi VC, and Kevin Durant. This interdisciplinary team based in San Carlos, CA is comprised of pioneers in fields such applied math, computational physics, electrical engineering, genetics, and radiology, hail from a dizzying array of home countries and cultural backgrounds.

Funding History

January 2016$7.5M
January 2018$16.5M
February 2020$60.0M

Management

Founder, CEO & CTO

Jeffrey Kaditz

COO

Clarissa Shen

Founder & Chief Medical Officer

Garry Choy

Founder

Michael Snyder

Board Member

Vinod Khosla

VP of Platform Engineering

Jyotindra Vasudeo

Investor

Patrick Schneider-Sikorsky

VP of Radiomics

Thomas Witzel

Board Member

Vijay Pande

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 290K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo